HENGELER MUELLER

Comment: This highly recommended healthcare practice impresses with its combination of industry-specific transaction experience and regulatory expertise. The latter is often displayed by the team around Spoerr and Uwer in precedent proceedings relevant to the healthcare industry. Besides the increased need for advice on strategic compliance, the spotlight was recently placed on the field of e-health, where Hengeler extensively advised, e.g., Royal Philips. Work in the area of medical centers and hospital transactions still makes for a strong pillar. On the downside, competitors perceive the previous year’s departure of an experienced counsel who worked at the interface with social law (to McDermott) as a loss to the practice. On the other hand, a senior associate is gaining more and more attention in the market for all the right reasons.
Strengths: Advice on EU and regulatory issues, ?M&A transactions in the healthcare sector.
Recommended: Prof. Dr. Wolfgang Spoerr (“pleasant lawyer, knows the industry”, competitor), Dr. Dirk Uwer.
Practice: Clear specialties in EU law, pharma advertising and reimbursement and regulatory issues; distribution and public law. Also clinical trials, medical products, transactions ( ?M&A), ?patents and antitrust. Also ?compliance. Frequent advice and litigation on fundamental issues, mainly for research companies but also for health insurers. (5 partners, 1 counsel, 7 associates)
Clients: ?? Sonic Healthcare on acquisition of Staber laboratory group and Medizinisches Labor Bremen; Royal Philips on e-health; GSK on German law to increase the provision of drugs under statutory health insurance (AMVSG); regulatory advice to Dompé Farmaceutici on market entry in Germany; Lilly Deutschland on pharma advertising; Sanofi in landmark administrative proceedings concerning data exclusivity.
  • Teilen